10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
GILEAD SCIENCES, INC. | |||
Ticker: GILD Fiscal Year: 2019 | |||
Consolidated Statements of Income | |||
Period Ending Dec 31, 2019 10-K (Filed: Feb 25, 2020) | |||
| (In Millions) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
| Revenues | |||
| Revenues | $ 22,449 | 22,127 | 26,107 |
| Costs and Expenses | |||
| Cost of goods sold | 4,675 | 4,853 | 4,371 |
| Research and development expenses | 9,106 | 5,018 | 3,734 |
| Selling, general and administrative expenses | 4,381 | 4,056 | 3,878 |
| Total costs and expenses | 18,162 | 13,927 | 11,983 |
| Income from operations | 4,287 | 8,200 | 14,124 |
| Interest expense | (995) | (1,077) | (1,118) |
| Other income (expense), net | 1,868 | 676 | 523 |
| Income before provision for income taxes | 5,160 | 7,799 | 13,529 |
| Provision for income taxes | (204) | 2,339 | 8,885 |
| Net income | 5,364 | 5,460 | 4,644 |
| Net (loss) income attributable to noncontrolling interest | (22) | 5 | 16 |
| Net income attributable to Gilead | 5,386 | 5,455 | 4,628 |
| Net income per share attributable to Gilead common stockholders - basic | 4.24 | 4.20 | 3.54 |
| Shares used in per share calculation - basic | 1,270 | 1,298 | 1,307 |
| Net income per share attributable to Gilead common stockholders - diluted | 4.22 | 4.17 | 3.51 |
| Shares used in per share calculation - diluted | 1,277 | 1,308 | 1,319 |
| Product and Service | |||
| Product sales | |||
| Revenues | 22,119 | 21,677 | 25,662 |
| Royalty, contract and other revenues | |||
| Revenues | 330 | 450 | 445 |
| External Links | |
| GILEAD SCIENCES, INC. (GILD) Fiscal Year 2019 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |